Endemic fluoroquinolone-resistant Salmonellaenterica serovar Kentucky ST198 in northern India

Microb Genom. 2019 Jul;5(7):e000275. doi: 10.1099/mgen.0.000275. Epub 2019 Jun 5.

Abstract

Salmonellaenterica serovar Kentucky is an emergent human pathogen. Human infection with ciprofloxacin-resistant S. enterica Kentucky ST198 has been reported in Europe and North America as a consequence of travel to Asia/the Middle East. This is, to the best of our knowledge, the first study reporting the identification of this epidemic clone in India and South Asia.

Keywords: India; antimicrobial resistance; fluoroquinolone; non-typhoidal Salmonella; whole-genome sequencing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Ciprofloxacin / pharmacology*
  • Ciprofloxacin / therapeutic use
  • DNA, Bacterial / genetics
  • Drug Resistance, Bacterial*
  • Humans
  • India / epidemiology
  • Phylogeny
  • Salmonella Infections, Animal / drug therapy
  • Salmonella Infections, Animal / epidemiology*
  • Salmonella Infections, Animal / microbiology*
  • Salmonella enterica / classification
  • Salmonella enterica / drug effects*
  • Salmonella enterica / genetics
  • Salmonella enterica / isolation & purification*
  • Serogroup
  • Whole Genome Sequencing

Substances

  • Anti-Bacterial Agents
  • DNA, Bacterial
  • Ciprofloxacin